Cala Health

company

About

Cala Health provides bioelectronic medicines, medical devices, and neurotherapeutics.

  • 51 - 100

Details

Last Funding Type
Series C
Last Funding Money Raised
$50M
Industries
Health Care,Medical,Neuroscience,Wearables
Founded date
Jan 1, 2014
Number Of Employee
51 - 100
Operating Status
Active

Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its vertically integrated commercial model is reshaping the delivery of prescription therapies. Cala Health’s lead product, Cala Trio™ therapy, is the only non-invasive prescription therapy for essential tremor. New therapies are under development in Parkinson’s disease and other indications in neurology, as well as targets in psychiatry, cardiology, and autoimmune disorders. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50M
Cala Health has raised a total of $50M in funding over 2 rounds. Their latest funding was raised on May 21, 2019 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 21, 2019 Series C $50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Cala Health is funded by 1 investors. Triventures are the most recent investors.
Investor Name Lead Investor Funding Round
Triventures Series C